Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04816643 |
|---|---|
| Brief Title: | A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children |
| First Submitted : | March 19, 2021 |
| First Submitted that Met QC Criteria : | March 24, 2021 |
| First Posted : | March 25, 2021 |
| Last Update Submitted that Met QC Criteria : | December 18, 2023 |
| Last Update Posted : | December 19, 2023 |